Gujarat Kidney IPO Analyzed
Gujarat Kidney and Super Speciality Hospital is planning to raise money by selling shares to the public. This is called an Initial Public Offering (IPO). They want to get ₹250.8 crore by selling 22 million shares to investors on December 22, 2025.
Key Points
- Gujarat Kidney sells shares to raise ₹250.8 crore.
- 75% of the shares go to big investors (QIBs).
- 10% for regular investors (Retail Investors).
- 15% for smaller investors (Non-Institutional Investors).
- Price range: ₹108 to ₹114 per share.
- Shares will be listed on the BSE and NSE on December 30, 2025.
IPO Details
Investors can buy shares in lots of 128 shares. The smallest investment for a regular investor is around ₹14,592. They can buy up to 13 lots, which is about 1,664 shares.
How the Money Will Be Used
The hospital needs the money for a new hospital in Vadodara, buying robot equipment, and paying off some debts.
Financial Results
In the last few months, the hospital made ₹15.26 crore in sales and earned ₹5.4 crore in profit. Over the last year, they made more than ₹400 crore in sales and over ₹9 crore in profit.
Important Dates
The IPO will be open for subscription until December 24, 2025. The results of who gets the shares will be known on December 26, 2025. Shares will be available to investors on December 29, 2025, and the shares will be traded on the BSE and NSE on December 30, 2025.
Companies Involved
MUFG Intime is helping with the IPO, and Nirbhay Capital Services is managing the sale of the shares.
“This IPO offers investors a chance to support a growing healthcare provider in India.”
